Supernus Pharmaceuticals | SUPN - Ebitda





Ebitda Perubahan Tanggal
Abbott USD 2.43B 844M 2026-03
ANI Pharmaceuticals USD 83.3M 11.7M 2026-09
Aurora Cannabis CAD 799K 2.9M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Canopy Growth CAD 8M 145M 2026-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD 42.16M 91.17M 2026-06
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Novo Nordisk DKK 37.36B 2.64B 2026-06
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 156.6M 83M 2026-09
Pfizer USD 6.36B 350M 2026-09
Supernus Pharmaceuticals USD 55.6M 24M 2026-09
United Therapeutics USD 334.2M 20.8M 2026-09
Xeris Pharmaceuticals USD -20.94M 33.27M 2026-06